Quick Answer
Pulmonx Corp reported Operating Income Loss of -$53.66 million for the year ending 2025.
- Pulmonx Corp showed an increase of +7.0% in Operating Income Loss from 2024 to 2025.
- This data is from Pulmonx Corp's annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2018 to 2025), Pulmonx Corp's Operating Income Loss has declined by 256.5%.
- Historical annual values: Fiscal year 2025: -$53.66 million | Fiscal year 2024: -$57.70 million | Fiscal year 2023: -$61.94 million | Fiscal year 2022: -$58.64 million | Fiscal year 2021: -$47.30 million | Fiscal year 2020: -$32.33 million | Fiscal year 2019: -$17.84 million | Fiscal year 2018: -$15.05 million.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: